Lidocaine Hci And Dextrose 51662-1565
Product NDC
51662-1565- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 17, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA019830
Need to source Lidocaine Hci And Dextrose? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dextrose Monohydrate | 5 g/100mL |
| Lidocaine Hydrochloride Anhydrous | .8 g/100mL |
Drug Class
Amide Local Anesthetic [EPC]Amides [CS]Antiarrhythmic [EPC]
Packaging Options(1)
250 mL in 1 CONTAINER (51662-1565-1)